Home
Philosophy
Portfolio
Team
Scientific Advisory Board
Ray Dolby’s Legacy
News
Contact
Tetra Therapeutics announces positive topline results from Phase 2 study of BPN14770 in patients with Fragile X Syndrome
Comments are closed.
Dolby Family Ventures Participates in Wickr $30 Million Series B Round
DigiLens Secures Investment from UDC Ventures and Samsung Ventures for Holographic AR Displays
Cleantech Expert Tom Werner Named Chairman of H2U as Company Advances Commercialization of New Green Hydrogen Technology
EarGo Raises Series C Funding
